DR SID Hématologie: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DR SID Hématologie
Largest movements
- Tangible fixed assets -€6,971
down €6,971 (-31.4%), from €22,186 to €15,215
of which Furniture and vehicles: -€6,844
- Cash -€5,562
down €5,562 (-28.1%), from €19,771 to €14,209
mainly Contributions, distributions and other (-€117,556) and Other debts (-€4,502)
- Receivables within one year +€1,916
up €1,916 (+5.7%), from €33,726 to €35,642
- Other debts -€4,502
down €4,502 (-6.9%), from €65,057 to €60,556
- Tax, wage and social debts -€4,130
down €4,130 (-46.8%), from €8,826 to €4,696
- Trade debts -€1,771
down €1,771 (-53.0%), from €3,344 to €1,573
- Taxes -€4,479
down €4,479 (-10.1%), from €44,188 to €39,709
- Gross operating margin +€4,203
up €4,203 (+2.6%), from €161,227 to €165,430
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €77,413 | €67,011 | -€10,402 | -13.4% |
| Formation expenses | 20 | €0 | - | = | |
| Fixed assets | 21/28 | €22,186 | €15,215 | -€6,971 | -31.4% |
| Tangible fixed assets | 22/27 | €22,186 | €15,215 | -€6,971 | -31.4% |
| Plant, machinery and equipment | 23 | €127 | - | -€127 | |
| Furniture and vehicles | 24 | €22,059 | €15,215 | -€6,844 | -31.0% |
| Current assets | 29/58 | €55,227 | €51,796 | -€3,431 | -6.2% |
| Amounts receivable within one year | 40/41 | €33,726 | €35,642 | +€1,916 | +5.7% |
| Other amounts receivable | 41 | €33,726 | €35,642 | +€1,916 | +5.7% |
| Cash at bank and in hand | 54/58 | €19,771 | €14,209 | -€5,562 | -28.1% |
| Deferred charges and accrued income | 490/1 | €1,730 | €1,945 | +€214 | +12.4% |
| Total equity and liabilities | 10/49 | €77,413 | €67,011 | -€10,402 | -13.4% |
| Equity | 10/15 | €186 | €186 | = | 0.0% |
| Contributions | 10/11 | €186 | €186 | = | 0.0% |
| Reserves | 13 | €0 | - | = | |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Amounts payable | 17/49 | €77,227 | €66,825 | -€10,402 | -13.5% |
| Amounts payable within one year | 42/48 | €77,227 | €66,825 | -€10,402 | -13.5% |
| Trade debts | 44 | €3,344 | €1,573 | -€1,771 | -53.0% |
| Suppliers | 440/4 | €3,344 | €1,573 | -€1,771 | -53.0% |
| Taxes, remuneration and social security | 45 | €8,826 | €4,696 | -€4,130 | -46.8% |
| Taxes | 450/3 | €8,826 | €4,696 | -€4,130 | -46.8% |
| Other amounts payable | 47/48 | €65,057 | €60,556 | -€4,502 | -6.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,756 | €7,628 | -€128 | -1.6% |
| Other operating charges | 640/8 | €318 | €558 | +€240 | +75.6% |
| Gross operating margin | 9900 | €161,227 | €165,430 | +€4,203 | +2.6% |
| Operating profit (loss) | 9901 | €153,154 | €157,245 | +€4,091 | +2.7% |
| Financial income | 75/76B | €182 | €100 | -€82 | -45.2% |
| Recurring financial income | 75 | €182 | €100 | -€82 | -45.2% |
| Financial charges | 65/66B | €90 | €80 | -€10 | -11.1% |
| Recurring financial charges | 65 | €90 | €80 | -€10 | -11.1% |
| Profit (loss) for the period before taxes | 9903 | €153,245 | €157,264 | +€4,019 | +2.6% |
| Income taxes | 67/77 | €44,188 | €39,709 | -€4,479 | -10.1% |
| Profit (loss) for the period | 9904 | €109,057 | €117,556 | +€8,498 | +7.8% |
| Profit (loss) for the period to be appropriated | 9905 | €109,057 | €117,556 | +€8,498 | +7.8% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.